Log in
Enquire now
‌

US Patent 9290475 3-(substituted-4-oxoquinazolin-3(4

Patent 9290475 was granted and assigned to DeuteRx on March, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
DeuteRx
0
Current Assignee
‌
DeuteRx
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
92904750
Patent Inventor Names
Sheila DeWitt0
Date of Patent
March 22, 2016
0
Patent Application Number
142118890
Date Filed
March 14, 2014
0
Patent Citations Received
‌
US Patent 11773080 Deuterium-enriched isoindolinonyl-azepanediones and related compounds and methods of treating medical disorders using same
Patent Primary Examiner
‌
Paul V Ward
0
Patent abstract

The invention provides 3-deuterium-enriched 3-(6-, 7-, or 8-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9290475 3-(substituted-4-oxoquinazolin-3(4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.